Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy

BACKGROUND: There is growing evidence that antibody responses play a role in the resolution of SARS-CoV-2 infection. Patients with primary or secondary antibody deficiency are at increased risk of persistent infection. This challenging clinical scenario is associated with adverse patient outcome and...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Yusri, Wardle, Hayley, Evans, Adam B., Hunter, Ewan R., Marr, Helen, Osborne, Wendy, Bashton, Matthew, Smith, Darren, Burton-Fanning, Shirelle, Schmid, Matthias L., Duncan, Christopher J. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717300/
https://www.ncbi.nlm.nih.gov/pubmed/34969393
http://dx.doi.org/10.1186/s12941-021-00491-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717300/
https://www.ncbi.nlm.nih.gov/pubmed/34969393
http://dx.doi.org/10.1186/s12941-021-00491-2

Ejemplares similares